MKC8866
CAS: 1338934-59-0
Ref. 3D-NDC93459
1mg | 164,00 € | ||
2mg | 280,00 € | ||
5mg | 556,00 € | ||
10mg | 954,00 € | ||
25mg | 2.019,00 € |
Información del producto
MKC8866 is an experimental anti-cancer drug that is currently in Phase II clinical trials. It has been shown to inhibit autophagy, which is the process of breaking down and recycling cellular components. This drug has also been shown to reduce protein synthesis and induce apoptosis in cancer cells. The effective dose for MKC8866 has not yet been determined, but it is expected to be between 0.5 and 1 milligrams per kilogram. MKC8866 has also been shown to have anticancer effects on a range of cancers including breast cancer, prostate cancer, lung cancer, ovarian cancer, pancreatic cancer, colon cancer, and gastric cancer.
Propiedades químicas
Consulta técnica sobre: 3D-NDC93459 MKC8866
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.